1
|
Duport A, Bédard S, Raynauld C, Bordeleau M, Neblett R, Balg F, Devanne H, Léonard G. Cross-cultural translation and psychometric validation of the French version of the Fear-Avoidance Components Scale (FACS). PLoS One 2023; 18:e0288899. [PMID: 37824567 PMCID: PMC10569597 DOI: 10.1371/journal.pone.0288899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Accepted: 09/20/2023] [Indexed: 10/14/2023] Open
Abstract
BACKGROUND The Fear-Avoidance Components Scale (FACS) is a reliable and valid instrument widely used to assess fear-avoidance beliefs related to pain and disability. However, there is a scarcity of validated translations of the FACS in different cultural and linguistic contexts, including the French population. This study aimed to translate and validate the French version of the FACS (FACS-Fr/CF), examining its psychometric properties among French-speaking individuals. METHODS A cross-cultural translation process-including forward translation, backward translation, expert committee review, and pre-testing-was conducted to develop the FACS-Fr/CF. The translated version was administered to a sample of French-speaking adults (n = 55) with chronic musculoskeletal pain. Internal consistency (including confirmatory analyses of the 2 factors identified in the Serbian version), test-retest reliability and convergent validity were then assessed. RESULTS The FACS-Fr/CF demonstrated high global internal consistency (α = 0.94, 95% CI: 0.91-0.96) as well as high internal consistency of the 2 factors identified in the Serbian version (α = 0.90, 95% CI: 0.86-0.94 and α = 0.90, 95% CI: 0.85-0.94, respectively). Test-retest analysis revealed a moderate (close to high) reliability (ICC = 0.89; 95% CI: 0.82-0.94 and r = 0.89; p<0.005). Convergent validity was supported by significant correlations between the FACS-Fr/CF scores and the Tampa Scale for Kinesiophobia (r = 0.82; p < 0.005), the Pain Catastrophizing Scale (r = 0.72; p < 0.005) and the Hospital Anxiety and Depression Scale (r = 0.66; p < 0.005). CONCLUSION The present study provides evidence for the cross-cultural translation and psychometric validation of the FACS-Fr/CF. The FACS-Fr/CF exhibits a high internal consistency, a moderate (close to high) test-retest reliability, and good construct validity, suggesting its utility in assessing fear-avoidance beliefs in the French-speaking population. This validated tool can enhance the assessment and understanding of fear-avoidance behaviors and facilitate cross-cultural research in pain-related studies.
Collapse
Affiliation(s)
- Arnaud Duport
- URePSSS—Unité de Recherche Pluridisciplinaire Sport Santé Société, ULR 7369, Université du Littoral Côte d’Opale, Université d’Artois, Université de Lille, Calais, France
- Research Center on Aging, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
| | - Sonia Bédard
- Centre de recherche du CHUS, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
- Surgery Department, Orthopedic Service, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Catherine Raynauld
- Centre de recherche du CHUS, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
- Surgery Department, Orthopedic Service, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Martine Bordeleau
- Research Center on Aging, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
| | - Randy Neblett
- PRIDE Research Foundation, Dallas, TX, United States of America
| | - Frédéric Balg
- Centre de recherche du CHUS, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
- Surgery Department, Orthopedic Service, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Hervé Devanne
- URePSSS—Unité de Recherche Pluridisciplinaire Sport Santé Société, ULR 7369, Université du Littoral Côte d’Opale, Université d’Artois, Université de Lille, Calais, France
| | - Guillaume Léonard
- Research Center on Aging, CIUSSS de l’Estrie-CHUS, Sherbrooke, Québec, Canada
- School of Rehabilitation, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada
| |
Collapse
|
2
|
Cuesta-Vargas AI, Biró A, Escriche-Escuder A, Trinidad-Fernández M, García-Conejo C, Roldán Jiménez CR, Tang W, Salvatore A, Nikolova B, Muro-Culebras A, Martín-Martín J, González-Sánchez M, Ruiz-Muñoz M, Mayoral F. Effectiveness of a gamified digital intervention based on lifestyle modification (iGAME) in secondary prevention: a protocol for a randomised controlled trial. BMJ Open 2023; 13:e066669. [PMID: 37316318 DOI: 10.1136/bmjopen-2022-066669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/16/2023] Open
Abstract
INTRODUCTION Combating physical inactivity and reducing sitting time are one of the principal challenges proposed by public health systems. Gamification has been seen as an innovative, functional and motivating strategy to encourage patients to increase their physical activity (PA) and reduce sedentary lifestyles through behaviour change techniques (BCT). However, the effectiveness of these interventions is not usually studied before their use. The main objective of this study will be to analyse the effectiveness of a gamified mobile application (iGAME) developed in the context of promoting PA and reducing sitting time with the BCT approach, as an intervention of secondary prevention in sedentary patients. METHODS AND ANALYSIS A randomised clinical trial will be conducted among sedentary patients with one of these conditions: non-specific low back pain, cancer survivors and mild depression. The experimental group will receive a 12-week intervention based on a gamified mobile health application using BCT to promote PA and reduce sedentarism. Participants in the control group will be educated about the benefits of PA. The International Physical Activity Questionnaire will be considered the primary outcome. International Sedentary Assessment Tool, EuroQoL-5D, MEDRISK Instruments and consumption of Health System resources will be evaluated as secondary outcomes. Specific questionnaires will be administered depending on the clinical population. Outcomes will be assessed at baseline, at 6 weeks, at the end of the intervention (12 weeks), at 26 weeks and at 52 weeks. ETHICS AND DISSEMINATION The study has been approved by the Portal de Ética de la Investigación Biomédica de Andalucía Ethics Committee (RCT-iGAME 24092020). All participants will be informed about the purpose and content of the study and written informed consent will be completed. The results of this study will be published in a peer-reviewed journal and disseminated electronically and in print. TRIAL REGISTRATION NUMBER NCT04019119.
Collapse
Affiliation(s)
- Antonio I Cuesta-Vargas
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Attila Biró
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
- ITware, Budapest, Hungary
- Department of Electrical Engineering and Information Technology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
| | - Adrian Escriche-Escuder
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Manuel Trinidad-Fernández
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Celia García-Conejo
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Cristina Roldán Roldán Jiménez
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Wen Tang
- Bournemouth University, Poole, UK
| | | | | | - Antonio Muro-Culebras
- Departamento de Fisioterapia, Universidad de Malaga, Andalucia Tech, Malaga, España
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
| | - Jaime Martín-Martín
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
- Departamento de Medicina Legal, Universidad de Malaga, Málaga, España
| | | | - María Ruiz-Muñoz
- Departamento de Enfermeria, Universidad de Malaga, Malaga, España
| | - Fermin Mayoral
- Instituto de Investigacion Biomédica de Málaga (IBIMA), Malaga, España
- Salud Mental, Hospital Regional Universitario de Malaga, Malaga, Spain
| |
Collapse
|
3
|
Roldán-Jiménez C, Martín-Martín J, Pajares B, Ribelles N, Alba E, Cuesta-Vargas AI. Factors associated with upper limb function in breast cancer survivors. PM R 2023; 15:151-156. [PMID: 34713595 DOI: 10.1002/pmrj.12731] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Revised: 09/24/2021] [Accepted: 10/25/2021] [Indexed: 12/15/2022]
Abstract
BACKGROUND Breast cancer survivors may have side effects from treatment, such as impaired upper limb function after surgery, which may be affected by a range of factors. OBJECTIVE To analyze the association between upper limb function and strength, fear avoidance, and central sensitization symptoms among breast cancer survivors, and to explore how these variables are associated with upper limb function. DESIGN Validation cohort. SETTING Institutional practice at a public hospital. PATIENTS One hundred seventy-four breast cancer survivors who had been undergone surgery for a primary tumor. INTERVENTIONS Not applicable. MAIN OUTCOME MEASURE Upper limb function was measured by the Upper Limb Functional Index (ULFI-Sp). Independent outcomes were: handgrip strength, which was measured using a Jamar dynamometer on the dominant side; fear avoidance, measured using the Fear-Avoidance Components Scale (FACS-Sp); and central sensitization symptoms, which were measured using the Central Sensitisation Inventory (CSI-Sp). A linear regression model explaining the ULFI-Sp results was constructed with the variables. RESULTS The regression model was significant (F = 46.826; p < .0001), and explained 45% of the variance of the ULFI values. All variables showed strong associations with upper limb function. CONCLUSIONS Greater upper limb function is associated with higher grip strength, lower fear-avoidance behavior and fewer central sensitization symptoms among breast cancer survivors. These variables explained 45% of the upper limb function in the regression model, and concur with earlier research showing that factors such as central sensitization symptoms and kinesiophobia negatively affect upper limb function in such patients. Clinicians should therefore take into account strength, fear avoidance, and central sensitization symptoms when considering interventions aimed at improving upper limb function among breast cancer survivors.
Collapse
Affiliation(s)
- Cristina Roldán-Jiménez
- Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Málaga, Andalucía Tech., Málaga, Spain.,Instituto de Investigación Biomédica de Málaga (IBIMA), Grupo de Clinimetría (F-14), Málaga, Spain
| | - Jaime Martín-Martín
- Instituto de Investigación Biomédica de Málaga (IBIMA), Grupo de Clinimetría (F-14), Málaga, Spain.,Department of Human Anatomy, Legal Medicine and History of Science; Area of Legal Medicine, University of Málaga, Faculty of Medicine, Málaga, Spain
| | - Bella Pajares
- Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Nuria Ribelles
- Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - Emilio Alba
- Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - Antonio I Cuesta-Vargas
- Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Málaga, Andalucía Tech., Málaga, Spain.,Instituto de Investigación Biomédica de Málaga (IBIMA), Grupo de Clinimetría (F-14), Málaga, Spain.,School of Clinical Science, Faculty of Health Science, Queensland University Technology, Brisbane, Queensland, Australia
| |
Collapse
|
4
|
Pérez‐Cruzado D, Roldan‐Jimenez C, Iglesias‐Campos M, Pajares B, Alba E, Cuesta‐Vargas A. Validation of pain catastrophizing scale on breast cancer survivor. Pain Pract 2022; 22:711-717. [PMID: 36136052 PMCID: PMC9828215 DOI: 10.1111/papr.13163] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Revised: 06/23/2022] [Accepted: 09/19/2022] [Indexed: 01/12/2023]
Abstract
INTRODUCTION Pain catastrophizing scale (PCS) is the most used scale to measure pain catastrophizing. In breast cancer survivors (BCS), pain catastrophizing is related to upper-limbs dysfunction and disability. This study aimed to assess the internal consistency, internal structure, and convergent validity of the Spanish version of the PCS in Spanish BCS. MATERIAL AND METHODS Breast cancer survivors were recruited from the service of Medical Oncology of the University Clinical Hospital Virgen de la Victoria, in Málaga (Spain). The psychometric properties were evaluated with analysis factor structure by maximum likelihood extraction (MLE), internal consistency, and construct validity by confirmatory factor analysis (CFA). RESULTS Factor structure was three-dimensional, and one item was removed due to cross-loading. The new 12-item PCS showed a high internal consistency for the total score (α = 0.91) and a good homogeneity, and CFA revealed a satisfactory fit. PCS showed an acceptable correlation with FACS (r = 0.53, p < 0.01). CONCLUSION Pain catastrophizing scale is a valid and reliable instrument to evaluate pain catastrophizing in Spanish BCS. This tool may help clinicians in the management of pain by assessing pain and by measuring the effect of interventions.
Collapse
Affiliation(s)
- David Pérez‐Cruzado
- Departamento de Fisioterapia, Facultad de Ciencias de la SaludUniversidad de Málaga, Andalucía Tech.MálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA) Grupo de Clinimetría (F‐14)MálagaColombia
| | - Cristina Roldan‐Jimenez
- Departamento de Fisioterapia, Facultad de Ciencias de la SaludUniversidad de Málaga, Andalucía Tech.MálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA) Grupo de Clinimetría (F‐14)MálagaColombia
| | - Marcos Iglesias‐Campos
- UGCI Oncología Médica Hospitales Universitarios Regional y Virgen de la VictoriaMálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA)MálagaSpain
| | - Bella Pajares
- UGCI Oncología Médica Hospitales Universitarios Regional y Virgen de la VictoriaMálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA)MálagaSpain
| | - Emilio Alba
- UGCI Oncología Médica Hospitales Universitarios Regional y Virgen de la VictoriaMálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA)MálagaSpain
| | - Antonio Cuesta‐Vargas
- Departamento de Fisioterapia, Facultad de Ciencias de la SaludUniversidad de Málaga, Andalucía Tech.MálagaColombia,Instituto de Investigación Biomédica de Málaga (IBIMA) Grupo de Clinimetría (F‐14)MálagaColombia,School of Clinical Science, Faculty of Health ScienceQueensland University TechnologyBrisbaneQueenslandAustralia
| |
Collapse
|
5
|
Gutiérrez-Sánchez D, Pajares-Hachero BI, Trinidad-Fernández M, Escriche-Escuder A, Iglesias-Campos M, Bermejo-Pérez MJ, Alba-Conejo E, Roldán-Jiménez C, Cuesta-Vargas A. The Benefits of a Therapeutic Exercise and Educational Intervention Program on Central Sensitization Symptoms and Pain-Related Fear Avoidance in Breast Cancer Survivors. Pain Manag Nurs 2022; 23:467-472. [PMID: 35277360 DOI: 10.1016/j.pmn.2022.01.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 11/26/2021] [Accepted: 01/07/2022] [Indexed: 10/18/2022]
Abstract
BACKGROUND Central sensitization symptoms and pain-related fear avoidance are two common problems in breast cancer survivors. Non-pharmacologic interventions such as therapeutic exercise and patient education can be effective in this population. AIMS This study aimed to: (1) analyze the benefits of a therapeutic exercise and educational program on central sensitization symptoms and pain-related fear avoidance in breast cancer survivors, and (2) explore the association between pain-related fear avoidance and central sensitization symptoms. DESIGN A single group pre-post intervention study was conducted. METHODS Patients were recruited from the service of Medical Oncology of the University Clinical Hospital Virgen de la Victoria, in Málaga (Spain). The intervention consisted of a therapeutic exercise and educational program that lasted 12 weeks, twice a week, for 1 hour. Two instruments were used: the Spanish version of the Central Sensitization Inventory and the Spanish Fear Avoidance Components Scale. RESULTS A total of 82 breast cancer survivors participated in the study. Pre-post change on Central Sensitization Inventory was statistically significant (p = .007). There was a trend towards a significant difference for the Spanish Fear Avoidance Components Scale (p = .062). There was a statistically significant correlation between pain-related fear avoidance and central sensitization symptoms (r = 0.536, p < .001). CONCLUSIONS The current study has provided preliminary evidence on the benefits of this intervention in pain-related fear avoidance and central sensitization symptoms in breast cancer survivors. The Spanish version of the Central Sensitization Inventory and the Spanish Fear Avoidance Components Scale demonstrated responsiveness to change.
Collapse
Affiliation(s)
- Daniel Gutiérrez-Sánchez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; Departamento de Enfermería, Facultad de Ciencias de la Salud, Universidad de Málaga, Spain
| | | | - Manuel Trinidad-Fernández
- Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Málaga, Andalucia Tech, Spain
| | - Adrian Escriche-Escuder
- Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; Departamento de Enfermería, Facultad de Ciencias de la Salud, Universidad de Málaga, Spain
| | - Marcos Iglesias-Campos
- Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria (IBIMA), Málaga
| | | | | | - Cristina Roldán-Jiménez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Málaga, Andalucia Tech, Spain.
| | - Antonio Cuesta-Vargas
- Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Málaga, Andalucia Tech, Spain; School of Clinical Science, Faculty of Health Science, Queensland University Technology, Australia
| |
Collapse
|